Synonyms: | |
Status: | Phase 2 |
Entry Type: | Antibody |
Molecule Category: | UNKNOWN |
UNII: | 3FO6689MSD |
Action | Mechanism of Action | Reference |
---|---|---|
BINDING AGENT | Complement C5 binding agent | PubMed ClinicalTrials |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Macular Degeneration | 2 | D008268 | ClinicalTrials |
Wet Macular Degeneration | 2 | D057135 | ClinicalTrials |
Uveitis, Intermediate | 2 | D015867 | ClinicalTrials |
Hemoglobinuria, Paroxysmal | 2 | D006457 | ClinicalTrials |
Resources | Reference |
---|---|
ChEMBL | CHEMBL4298012 |
FDA SRS | 3FO6689MSD |